DarioHealth Corp. SEC filings DRIO

DarioHealth Corp. has 903 filings in SEC EDGAR's recent list, going back to Nov 1, 2011. Its latest annual report, Form 10-K, was filed on Mar 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 4, 2026 (officer or director change). The company's fiscal year ends on December 31.

DarioHealth Corp. SEC filings
Form Description Filed Period
8-K Current report
Officer or director change
Sep 4, 2026 Sep 2, 2026
8-K Current report
Officer or director change
Aug 21, 2026 Aug 20, 2026
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
8-K Current report
Material agreement, Other events
Jul 22, 2026 Jul 22, 2026
424B5 Prospectus supplement Jul 22, 2026 —
8-K Current report
Officer or director change
Jul 10, 2026 Jul 10, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
SD Specialized disclosure (conflict minerals) May 7, 2026 —
8-K Current report
Officer or director change, Other events
Apr 13, 2026 Apr 10, 2026
424B5 Prospectus supplement Mar 30, 2026 —
8-K Current report
Material agreement
Mar 30, 2026 Mar 30, 2026
EFFECT Filing Mar 27, 2026 —
CORRESP Letter to the SEC Mar 25, 2026 —
UPLOAD Letter from the SEC Mar 25, 2026 —
S-8 Employee stock plan registration Mar 19, 2026 —
S-3 Shelf registration Mar 19, 2026 —
10-K Annual report Mar 19, 2026 Dec 31, 2025
8-K Current report
Bylaw or fiscal year change
Feb 2, 2026 Feb 2, 2026
8-K Current report
Shareholder vote results
Jan 29, 2026 Jan 29, 2026
EFFECT Filing Jan 8, 2026 —
CORRESP Letter to the SEC Jan 6, 2026 —
S-3/A Form s-3/a Dec 29, 2025 —
ARS Annual report to shareholders Dec 22, 2025 Dec 31, 2024
DEF 14A Proxy statement Dec 22, 2025 Jan 29, 2026
PRE 14A Preliminary proxy statement Dec 11, 2025 Dec 11, 2025
10-Q Quarterly report Nov 13, 2025 Sep 30, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
Nov 10, 2025 Nov 5, 2025
S-3 Shelf registration Oct 20, 2025 —
D Filing Oct 7, 2025 —
8-K Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
Sep 25, 2025 Sep 25, 2025
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 19, 2025 Sep 18, 2025
8-K Current report
Other events
Sep 12, 2025 Sep 12, 2025
8-K Current report
Bylaw or fiscal year change, Other events
Aug 25, 2025 Aug 25, 2025
10-Q Quarterly report Aug 12, 2025 Jun 30, 2025
EFFECT Filing Aug 7, 2025 —
CORRESP Letter to the SEC Aug 5, 2025 —
UPLOAD Letter from the SEC Aug 5, 2025 —
S-3 Shelf registration Jul 31, 2025 —
8-K Current report
Shareholder vote results
Jul 23, 2025 Jul 23, 2025
8-K Current report
Officer or director change
Jul 10, 2025 Jul 10, 2025
EFFECT Filing Jun 5, 2025 —
CORRESP Letter to the SEC Jun 4, 2025 —
UPLOAD Letter from the SEC Jun 2, 2025 —
SD Specialized disclosure (conflict minerals) Jun 2, 2025 —
DEF 14A Proxy statement May 30, 2025 Jul 23, 2025
8-K Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
May 29, 2025 May 23, 2025
S-3 Shelf registration May 28, 2025 —
8-K Current report
Bylaw or fiscal year change
May 21, 2025 May 20, 2025
PRE 14A Preliminary proxy statement May 20, 2025 May 20, 2025
10-Q Quarterly report May 14, 2025 Mar 31, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale
May 6, 2025 Apr 30, 2025
8-K Current report
Shareholder vote results
Apr 28, 2025 Apr 28, 2025
8-K Current report
Officer or director change
Apr 21, 2025 Apr 18, 2025
8-K Current report
Listing notice
Mar 19, 2025 Mar 18, 2025
8-K Current report
Officer or director change
Mar 14, 2025 Mar 12, 2025
DEF 14A Proxy statement Mar 10, 2025 Apr 28, 2025
10-K Annual report Mar 10, 2025 Dec 31, 2024
PRE 14A Preliminary proxy statement Feb 28, 2025 Feb 28, 2025
8-K Current report
Officer or director change, Other events
Feb 27, 2025 Feb 24, 2025
8-K Current report
Other events
Jan 22, 2025 Jan 21, 2025
D Filing Jan 17, 2025 —
D Filing Jan 17, 2025 —
S-8 Employee stock plan registration Jan 17, 2025 —
8-K Current report
Material agreement, Unregistered share sale
Jan 10, 2025 Jan 7, 2025
8-K Current report
Material agreement, New debt, Unregistered share sale, Other events
Dec 18, 2024 Dec 16, 2024
8-K Current report
Shareholder vote results
Dec 18, 2024 Dec 18, 2024
10-Q Quarterly report Nov 7, 2024 Sep 30, 2024
DEF 14A Proxy statement Oct 24, 2024 Dec 18, 2024
8-K Current report
Listing notice
Sep 20, 2024 Sep 16, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Sep 13, 2024 Sep 11, 2024
10-Q Quarterly report Aug 8, 2024 Jun 30, 2024
S-8 Employee stock plan registration Jul 5, 2024 —
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jun 28, 2024 Jun 25, 2024
8-K Current report
Officer or director change, Shareholder vote results
Jun 25, 2024 Jun 25, 2024
8-K Current report
Officer or director change
Jun 5, 2024 Jun 5, 2024
10-Q Quarterly report May 15, 2024 Mar 31, 2024
EFFECT Filing May 8, 2024 —
CORRESP Letter to the SEC May 6, 2024 —
S-3/A Form s-3/a May 3, 2024 —
DEF 14A Proxy statement May 1, 2024 Jun 25, 2024
UPLOAD Letter from the SEC Apr 30, 2024 —
S-3 Shelf registration Apr 22, 2024 —
8-K Current report
Acquisition or sale of assets
Apr 22, 2024 Feb 15, 2024
PRE 14A Preliminary proxy statement Apr 19, 2024 Jun 25, 2024
8-K Current report
Bylaw or fiscal year change
Apr 19, 2024 Apr 16, 2024
424B3 Prospectus Apr 19, 2024 —
8-K Current report
Officer or director change
Apr 5, 2024 Apr 4, 2024
10-K Annual report Mar 28, 2024 Dec 31, 2023
8-K Current report
Other events
Mar 1, 2024 Mar 1, 2024
D Filing Feb 29, 2024 —
8-K Current report
Regulation FD disclosure
Feb 22, 2024 Feb 22, 2024
S-8 Employee stock plan registration Feb 21, 2024 —
8-K Current report
Material agreement, New debt, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
Feb 21, 2024 Feb 15, 2024
S-8 Employee stock plan registration Jan 19, 2024 —
8-K Current report
Shareholder vote results
Dec 11, 2023 Dec 11, 2023
10-Q Quarterly report Nov 2, 2023 Sep 30, 2023
DEF 14A Proxy statement Oct 26, 2023 Dec 11, 2023
8-K Current report
Regulation FD disclosure
Oct 17, 2023 Oct 17, 2023
PRE 14A Preliminary proxy statement Oct 16, 2023 Dec 11, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations, Other events
Jul 24, 2023 Jul 24, 2023
EFFECT Filing Jul 13, 2023 —
CORRESP Letter to the SEC Jul 12, 2023 —
S-3/A Form s-3/a Jul 10, 2023 —
UPLOAD Letter from the SEC Jul 7, 2023 —
S-3 Shelf registration Jun 29, 2023 —
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change
Jun 20, 2023 Jun 14, 2023
SD Specialized disclosure (conflict minerals) Jun 7, 2023 —
D Filing May 16, 2023 —
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K/A Amended current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Bylaw or fiscal year change, Other events
May 9, 2023 May 1, 2023
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale, Bylaw or fiscal year change, Other events
May 5, 2023 May 1, 2023
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
10-K Annual report Mar 9, 2023 Dec 31, 2022
8-K Current report
Officer or director change, Other events
Feb 24, 2023 Feb 22, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Feb 6, 2023 Jan 31, 2023
8-K Current report
Officer or director change
Jan 27, 2023 Jan 23, 2023
8-K Current report
Other events
Jan 13, 2023 Jan 9, 2023
EFFECT Filing Jan 12, 2023 —
CORRESP Letter to the SEC Jan 9, 2023 —
S-8 Employee stock plan registration Jan 6, 2023 —
UPLOAD Letter from the SEC Jan 6, 2023 —
S-3 Shelf registration Dec 30, 2022 —
8-K Current report
Officer or director change, Shareholder vote results
Dec 7, 2022 Dec 7, 2022
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
DEF 14A Proxy statement Oct 14, 2022 Dec 7, 2022
8-K Current report Oct 3, 2022 Oct 3, 2022
8-K Current report
Results of operations
Aug 15, 2022 Aug 15, 2022
10-Q Quarterly report Aug 15, 2022 Jun 30, 2022
EFFECT Filing Jul 12, 2022 —
CORRESP Letter to the SEC Jul 11, 2022 —
UPLOAD Letter from the SEC Jul 8, 2022 —
S-3 Shelf registration Jul 1, 2022 —
8-K Current report
Material agreement, New debt, Other events
Jun 13, 2022 Jun 9, 2022
8-K Current report
Officer or director change
Jun 6, 2022 May 30, 2022
SD Specialized disclosure (conflict minerals) May 13, 2022 —
10-Q Quarterly report May 12, 2022 Mar 31, 2022
8-K Current report
Acquisition or sale of assets
Apr 1, 2022 Mar 31, 2022
10-K Annual report Mar 22, 2022 Dec 31, 2021
8-K Current report
Material agreement
Mar 4, 2022 Feb 28, 2022
424B5 Prospectus supplement Mar 2, 2022 —
8-K Current report
Material agreement, Other events
Mar 2, 2022 Feb 28, 2022
8-K Current report
Material agreement, Results of operations
Jan 19, 2022 Jan 18, 2022
S-8 Employee stock plan registration Jan 7, 2022 —
424B5 Prospectus supplement Dec 23, 2021 —
8-K Current report
Officer or director change
Nov 29, 2021 Nov 25, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
EFFECT Filing Nov 12, 2021 —
CORRESP Letter to the SEC Nov 10, 2021 —
UPLOAD Letter from the SEC Oct 28, 2021 —
S-3 Shelf registration Oct 22, 2021 —
8-K Current report
Material agreement
Oct 22, 2021 Oct 22, 2021
8-K Current report
Results of operations
Aug 16, 2021 Aug 16, 2021
10-Q Quarterly report Aug 16, 2021 Jun 30, 2021
8-K Current report
Bylaw or fiscal year change, Other events
Jul 9, 2021 Jul 8, 2021
D Filing Jun 17, 2021 —
8-K Current report
Acquisition or sale of assets, Other events
Jun 8, 2021 Jun 7, 2021
S-8 Employee stock plan registration Jun 8, 2021 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 7, 2021 Jun 7, 2021
SD Specialized disclosure (conflict minerals) May 25, 2021 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
May 18, 2021 May 15, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
DEF 14A Proxy statement Apr 26, 2021 Jun 7, 2021
PRE 14A Preliminary proxy statement Apr 16, 2021 Jun 7, 2021
EFFECT Filing Apr 9, 2021 —
CORRESP Letter to the SEC Apr 7, 2021 —
UPLOAD Letter from the SEC Apr 6, 2021 —
S-3 Shelf registration Apr 1, 2021 —
8-K/A Amended current report
Acquisition or sale of assets
Apr 1, 2021 Feb 1, 2021
10-K Annual report Mar 9, 2021 Dec 31, 2020
25-NSE Delisting notice Mar 4, 2021 —
D Filing Feb 17, 2021 —
8-K Current report
Acquisition or sale of assets, Officer or director change, Regulation FD disclosure
Feb 4, 2021 Feb 1, 2021
D Filing Feb 3, 2021 —
8-K Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
Jan 28, 2021 Jan 26, 2021
S-8 Employee stock plan registration Jan 8, 2021 —
10-Q Quarterly report Nov 12, 2020 Sep 30, 2020
S-8 Employee stock plan registration Oct 14, 2020 —
8-K Current report
Officer or director change, Shareholder vote results
Oct 14, 2020 Oct 14, 2020
EFFECT Filing Sep 18, 2020 —
CORRESP Letter to the SEC Sep 16, 2020 —
UPLOAD Letter from the SEC Sep 15, 2020 —
S-3 Shelf registration Sep 8, 2020 —
DEF 14A Proxy statement Sep 2, 2020 Oct 14, 2020
10-Q Quarterly report Aug 12, 2020 Jun 30, 2020
D Filing Aug 4, 2020 —
8-K Current report
Material agreement, Unregistered share sale
Jul 31, 2020 Jul 28, 2020
8-K Current report
Officer or director change
Jul 6, 2020 Jul 2, 2020
10-Q Quarterly report May 12, 2020 Mar 31, 2020
SD Specialized disclosure (conflict minerals) May 6, 2020 —
8-K Current report
Officer or director change
Apr 7, 2020 Apr 7, 2020
EFFECT Filing Mar 26, 2020 —
CORRESP Letter to the SEC Mar 25, 2020 —
S-3/A Filing Mar 25, 2020 —
UPLOAD Letter from the SEC Mar 24, 2020 —
8-K Current report
Unregistered share sale
Mar 23, 2020 Mar 17, 2020
S-3 Shelf registration Mar 19, 2020 —
10-K Annual report Mar 17, 2020 Dec 31, 2019
8-K Current report
Officer or director change
Mar 5, 2020 Mar 1, 2020
8-K Current report
Officer or director change
Feb 14, 2020 Feb 12, 2020

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
DRIO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
New York, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1533998
Former names
LabStyle Innovations Corp. (until Jul 27, 2016)

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.